OSAIC HOLDINGS, INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$746,690
+25.6%
19,547
+18.8%
0.00%0.0%
Q2 2023$594,734
+25.8%
16,457
+32.2%
0.00%0.0%
Q1 2023$472,897
-74.5%
12,449
-61.8%
0.00%
-75.0%
Q4 2022$1,854,211
+56.7%
32,616
+9.0%
0.00%
+33.3%
Q3 2022$1,183,000
-33.3%
29,924
-25.7%
0.00%
-25.0%
Q2 2022$1,774,000
+216.8%
40,300
+185.3%
0.00%
+300.0%
Q1 2022$560,000
-10.5%
14,125
-9.4%
0.00%0.0%
Q4 2021$626,000
-41.4%
15,589
-40.6%
0.00%
-50.0%
Q3 2021$1,068,000
+71.4%
26,263
+92.2%
0.00%
+100.0%
Q2 2021$623,000
+12.5%
13,662
+3.5%
0.00%0.0%
Q1 2021$554,000
-78.4%
13,202
-78.0%
0.00%
-85.7%
Q4 2020$2,569,000
+801.4%
60,125
+459.1%
0.01%
+600.0%
Q3 2020$285,000
-15.2%
10,754
-14.4%
0.00%0.0%
Q2 2020$336,000
+127.0%
12,557
+53.2%
0.00%0.0%
Q1 2020$148,0008,1990.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders